title: In vitro correction of ARSA deficiency in human skin fibroblasts from metachromatic leukodystrophy patients after treatment with microencapsulated recombinant cells.
abstract: Metachromatic leukodystrophy (MLD) is an autosomal recessive disorder due to arylsulfatase A (ARSA) deficiency that affects primarily the central nervous system. Ongoing treatments include enzyme replacement therapy and bone marrow transplantation, both limited in their effects due to the blood-brain barrier. An alternative approach would be the in situ implantation of encapsulated cells over expressing ARSA. Based on that, we tested the ability of encapsulated BHK cells over expressing ARSA to correct the enzyme deficiency in MLD patients' fibroblasts. Three groups were analyzed: fibroblasts treated with ARSA-over expressing BHK cells (rBHK) trapped in alginate capsules (capsules group), fibroblasts treated with supernatant of non-encapsulated rBHK (uptake control) and fibroblasts treated with empty capsules (empty group). Untreated and normal fibroblasts were used as controls. rBHK obtained by clone selection after non-viral transfection with pTARSA-CMV2. ARSA activity was measured after 1, 2, 3 and 4 weeks of treatment and beta-gal was used as reference enzyme. Statistical analysis was performed using ANOVA and Tukey's test. Normal fibroblasts showed ARSA activity of 23.9 + /- 2.01 nmol/h/mg of protein, whereas untreated MLD fibroblasts had the low ARSA activity (2.22 + /- 0.17). In the empty group, ARSA activity was equal to that of untreated fibroblasts (2.71 + /- 0.34). Capsules and uptake control groups showed higher enzymatic activity levels, compared to MLD untreated, 23.42 + /- 6.39 and 42.35 + /- 5.20, respectively (p < 0.01 for all groups). Encapsulated rBHK clones show potential as a new therapeutic strategy for the treatment of MLD, reaching normal enzyme levels in human MLD fibroblasts.
authors.affiliation: Postgraduate Program in Genetics and Molecular Biology, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil. valleska@gmail.com
authors.forename: Valeska Lizzi
authors.initials: VL
authors.lastname: Lagranha
authors.forename: Guilherme
authors.initials: G
authors.lastname: Baldo
authors.forename: Talita Giacomet
authors.initials: TG
authors.lastname: de Carvalho
authors.forename: Maira
authors.initials: M
authors.lastname: Burin
authors.forename: Maria Luiza
authors.initials: ML
authors.lastname: Saraiva-Pereira
authors.forename: Ursula
authors.initials: U
authors.lastname: Matte
authors.forename: Roberto
authors.initials: R
authors.lastname: Giugliani
mesh_terms: D000704:Analysis of Variance; D002214:Capsules; D017690:Cell Transplantation / Q000379:methods*; D002478:Cells, Cultured; D002553:Cerebroside-Sulfatase / Q000172:deficiency / Q000235:genetics*; D005347:Fibroblasts / Q000201:enzymology*; D005818:Genetic Engineering; D015316:Genetic Therapy / Q000379:methods; D005822:Genetic Vectors / Q000235:genetics / Q000627:therapeutic use*; D006801:Humans; D020007:Implants, Experimental; D007668:Kidney / Q000166:cytology; D007966:Leukodystrophy, Metachromatic / Q000201:enzymology / Q000235:genetics / Q000628:therapy*; D018709:Statistics, Nonparametric; D019076:Transgenes / Q000235:genetics
chemical_list: D002214:Capsules; D002553:Cerebroside-Sulfatase
references.citation: J Mol Cell Cardiol. 2003 Jul;35(7):823-31
references.pmid: 12818573
references.citation: J Biol Chem. 1989 May 15;264(14):8222-9
references.pmid: 2722778
references.citation: Glia. 2006 Mar;53(4):372-81
references.pmid: 16288467
references.citation: Mol Cell Biol. 1987 Nov;7(11):4125-9
references.pmid: 2828927
references.citation: J Pediatr. 2001 Apr;138(4):539-47
references.pmid: 11295718
references.citation: Virchows Arch. 2001 Jul;439(1):90-6
references.pmid: 11499846
references.citation: J Gene Med. 2005 Nov;7(11):1482-91
references.pmid: 15966019
references.citation: Exp Neurol. 2000 Dec;166(2):276-86
references.pmid: 11085893
references.citation: J Virol. 2001 Dec;75(24):12382-92
references.pmid: 11711628
references.citation: Acta Neuropathol. 2004 Oct;108(4):261-71
references.pmid: 15322834
references.citation: J Neurooncol. 2006 May;78(1):31-9
references.pmid: 16598433
references.citation: Mol Genet Metab. 2001 Mar;72(3):199-208
references.pmid: 11243725
references.citation: J Biol Chem. 1989 Jan 15;264(2):1252-9
references.pmid: 2562955
references.citation: Exp Neurol. 2008 Jan;209(1):82-8
references.pmid: 17963752
references.citation: Carcinogenesis. 2003 Oct;24(10):1625-35
references.pmid: 12869421
references.citation: Gene Ther. 2003 Aug;10(16):1275-81
references.pmid: 12883523
references.citation: Tohoku J Exp Med. 2006 May;209(1):23-32
references.pmid: 16636519
references.citation: Neuro Oncol. 2001 Jul;3(3):201-10
references.pmid: 11465401
references.citation: Hum Gene Ther. 2004 Oct;15(10):968-75
references.pmid: 15585112
references.citation: Am J Pathol. 1973 Oct;73(1):59-80
references.pmid: 4201373
references.citation: Nat Med. 2001 Mar;7(3):310-6
references.pmid: 11231629
references.citation: Cell Transplant. 1999 Jul-Aug;8(4):427-30
references.pmid: 10478724
references.citation: Hum Mol Genet. 2005 May 1;14(9):1139-52
references.pmid: 15772092
references.citation: J Postgrad Med. 2003 Apr-Jun;49(2):127-31
references.pmid: 12867687
references.citation: Mol Ther. 2005 May;11(5):754-62
references.pmid: 15851014
references.citation: Anticancer Res. 2002 Nov-Dec;22(6A):3325-30
references.pmid: 12530082
references.citation: J Gene Med. 2004 Apr;6(4):395-404
references.pmid: 15079814
references.citation: Clin Chim Acta. 1987 Apr 30;164(2):171-80
references.pmid: 2885112
references.citation: J Neurosci Methods. 2007 Apr 15;161(2):223-33
references.pmid: 17204333
references.citation: Hum Gene Ther. 2007 Sep;18(9):821-36
references.pmid: 17845130
references.citation: J Biol Chem. 1951 Nov;193(1):265-75
references.pmid: 14907713
references.citation: Nat Rev Genet. 2002 Dec;3(12):954-66
references.pmid: 12459725
references.citation: J Neurol Sci. 2007 Apr 15;255(1-2):7-16
references.pmid: 17341424
references.citation: J Inherit Metab Dis. 2001 Apr;24(2):245-50
references.pmid: 11405343
references.citation: Hum Gene Ther. 1992 Aug;3(4):371-9
references.pmid: 1525210